<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04932161</url>
  </required_header>
  <id_info>
    <org_study_id>SVSIDS/PERIO/4/2020</org_study_id>
    <nct_id>NCT04932161</nct_id>
  </id_info>
  <brief_title>Efficacy of Titanium Granules in the Treatment of Periodontal Intrabony Defects</brief_title>
  <official_title>Comparative Efficacy of Titanium Granules Over Hydroxyapatite in the Treatment of Periodontal Intrabony Defects: A Clinico-radiographic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SVS Institute of Dental Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SVS Institute of Dental Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ideal goal of the periodontal treatment is not only to prevent the progression of the&#xD;
      disease, but also the regeneration and reconstruction of lost tissues. Many surgical&#xD;
      techniques have been used to regenerate intrabony defects (IBD).&#xD;
&#xD;
      Titanium stimulates activation of the complement system, surface binding of platelets, and&#xD;
      platelet activation as reflected by increased levels of platelet-derived growth factor, which&#xD;
      is a substantial promoter of bone growth. Hence we may speculate that using a bone substitute&#xD;
      made of titanium may be positive from the perspective of bone formation in osseous defects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Titanium granules consist of irregular porous granules of commercially pure titanium. The&#xD;
      porous properties may lead to ingrowth of newly formed bone.The osseointegrating response to&#xD;
      titanium may be the result of the potent activation of the intrinsic coagulation system and&#xD;
      the subsequent release of growth factors from platelets.Therefore, the aim of this study is&#xD;
      to compare the effect of titanium particles and hydroxyapatite on osseous regeneration in&#xD;
      intrabony defects.&#xD;
&#xD;
      After reflection of flap and degranulation, bone graft i.e., titanium particles (test group)&#xD;
      or hydroxyapatite(control group) will be placed in the void created by the defect and sutures&#xD;
      will be placed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Attachment Level</measure>
    <time_frame>from baseline to 6 months</time_frame>
    <description>Assessment of clinical attachment level using UNC-15 probe at baseline and post operatively at 3 and 6 months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Probing Depth</measure>
    <time_frame>from baseline to 6 months</time_frame>
    <description>Assessment of probing depth using University of North Carolina(UNC)-15 probe at baseline and postoperatively at 3 and 6 months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone Regeneration</measure>
    <time_frame>at 3 months and 6 months</time_frame>
    <description>Radiovisiography (RVG) will be used to assess bone regeneration achieved post operatively after 3 months and 6 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plaque Index</measure>
    <time_frame>from baseline to 6 months</time_frame>
    <description>Assessment of plaque (PI) - according to Turesky modification of Quigley and Hein Plaque Index, 1970.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gingivitis</measure>
    <time_frame>from baseline to 6 months</time_frame>
    <description>Assessment of Gingivitis (GI) - according to Loe H and Silness P, 1963.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Intrabony Periodontal Defect</condition>
  <arm_group>
    <arm_group_label>Titanium Granules as a bone graft in intrabony defects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In test group, after reflection of flap and degranulation, bone graft i.e., titanium particles will be placed in the void created by the defect and sutures will be placed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydroxyapatite as a bone graft in intrabony defects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In control group, after reflection of flap and degranulation, bone graft i.e., hydroxyapatite will be placed in the defect and sutures will be placed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Titanium Granules</intervention_name>
    <description>After degranulation of the intrabony defect, titanium particles will be placed in the defect and will be sutured.</description>
    <arm_group_label>Titanium Granules as a bone graft in intrabony defects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hydroxyapatite</intervention_name>
    <description>After degranulation of the intrabony defect, hydroxyapatite will be placed in the defect and will be sutured.</description>
    <arm_group_label>Hydroxyapatite as a bone graft in intrabony defects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Systemically healthy male and female patients of age &gt;18 years with two-walled or&#xD;
        three-walled intrabony defects and probing pocket depths (PPD) of &gt;3mm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Medically compromised patients, patients &lt;18 years of age, pregnant women, heavy smokers,&#xD;
        and patients who underwent radiotherapy or chemotherapy are excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>R V Chandra, MDS;DNB;PhD</last_name>
    <phone>9908183071</phone>
    <email>viswachandra@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>SVS Institute of Dental Sciences, Mahabubnagar</name>
      <address>
        <city>Hyderabad</city>
        <state>Telangana</state>
        <zip>509002</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rampalli V Chandra, MDS; DNB</last_name>
      <phone>9908183071</phone>
      <email>viswachandra@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 17, 2021</study_first_submitted>
  <study_first_submitted_qc>June 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2021</study_first_posted>
  <last_update_submitted>June 17, 2021</last_update_submitted>
  <last_update_submitted_qc>June 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>SVS Institute of Dental Sciences</investigator_affiliation>
    <investigator_full_name>Dr R Viswa Chandra</investigator_full_name>
    <investigator_title>Primary Investigator</investigator_title>
  </responsible_party>
  <keyword>Intrabony defects</keyword>
  <keyword>Titanium Granules</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

